Thyroid hormone in health and disease

被引:159
作者
Boelaert, K [1 ]
Franklyn, JA [1 ]
机构
[1] Univ Birmingham, Sch Med, Div Med Sci, Birmingham B15 2TT, W Midlands, England
基金
英国惠康基金;
关键词
D O I
10.1677/joe.1.06131
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroid disease is common, affecting around 2% of wonien and 0-2% of men in the UK. Our understanding of the effects of thyroid hormones under physiological circumstances, as well as in pathological conditions, has increased dramatically during the last two centuries and it has become clear that overt thyroid dysfunction is associated with significant morbidity and mortality. Both hypo- and hyperthyroidism and their treatments have been linked with increased risk from cardiovascular disease and the adverse effects of thyrotoxicosis in terms of osteoporosis risk are well established. Although the evidence suggests that successful treatment of overt thyroid dysfunction significantly improves overall survival, the issue of treating mild or subdinical hyper- and hypothyroidism remains controversial. Furthermore, the now well-established effects of thyroid hormones on neurodevelopment have sparked a whole new debate regarding the need to screen pregnant women for thyroid function abnormalities. This review describes the current evidence of the effects of thyroid hormone on the cardiovascular, skeletal and neurological systems, as well as the influence of thyroid diseases and their treatments on the development of malignancy. Furthermore we will describe some recent developments in our understanding of the relationship between thyroid status and health.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 112 条
[1]   Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism [J].
Alexander, EK ;
Marqusee, E ;
Lawrence, J ;
Jarolim, P ;
Fischer, GA ;
Larsen, PR .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (03) :241-249
[2]  
[Anonymous], 1874, T CLIN SOC LOND
[3]   Subclinical hyperthyroidism as a risk factor for atrial fibrillation [J].
Auer, J ;
Scheibner, P ;
Mische, T ;
Langsteger, W ;
Eber, O ;
Eber, B .
AMERICAN HEART JOURNAL, 2001, 142 (05) :838-842
[4]   ARTERIAL EMBOLISM IN THYROTOXICOSIS WITH ATRIAL-FIBRILLATION [J].
BARSELA, S ;
EHRENFELD, M ;
ELIAKIM, M .
ARCHIVES OF INTERNAL MEDICINE, 1981, 141 (09) :1191-1192
[5]   Risk for fracture in women with low serum levels of thyroid-stimulating hormone [J].
Bauer, DC ;
Ettinger, B ;
Nevitt, MC ;
Stone, KL .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (07) :561-568
[6]   RADIOIODINE THERAPY FOR HYPERTHYROIDISM IN YOUNG-PATIENTS - PERCEPTION OF RISK AND USE [J].
BAXTER, MA ;
STEWART, PM ;
DAYKIN, J ;
SHEPPARD, MC ;
FRANKLYN, JA .
QUARTERLY JOURNAL OF MEDICINE, 1993, 86 (08) :495-499
[7]   Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study [J].
Bettendorf, M ;
Schmidt, KG ;
Grulich-Henn, J ;
Ulmer, HE ;
Heinrich, UE .
LANCET, 2000, 356 (9229) :529-534
[8]   CONTROL OF ADRENERGIC OVERACTIVITY BY BETA-BLOCKADE IMPROVES THE QUALITY-OF-LIFE IN PATIENTS RECEIVING LONG-TERM SUPPRESSIVE THERAPY WITH LEVOTHYROXINE [J].
BIONDI, B ;
FAZIO, S ;
CARELLA, C ;
SABATINI, D ;
AMATO, G ;
CITTADINI, A ;
BELLASTELLA, A ;
LOMBARDI, G ;
SACCA, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) :1028-1033
[9]   Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients [J].
Biondi, B ;
Palmieri, EA ;
Fazio, S ;
Cosco, C ;
Nocera, M ;
Saccà, L ;
Filetti, S ;
Lombardi, G ;
Perticone, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12) :4701-4705
[10]  
BLANK B, 1963, J MED CHEM, V19, P554